Neurofibrillary tangles and Alzheimer's disease

European Neurology

Volumn 40, Issue 3, 1998, Pages 130-140

  Brion, J P ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Alzheimer's disease; Microtubule; Microtubule associated protein tau; Neurofibrillary tangles; Phosphorylation

Indexed keywords

PHOSPHATASE; PROTEIN KINASE; TAU PROTEIN;

ALZHEIMER DISEASE; AMYLOIDOSIS; AXOPLASM FLOW; CEREBROSPINAL FLUID; DISEASE SEVERITY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MICROTUBULE; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; TRANSMISSION ELECTRON MICROSCOPY;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; HIPPOCAMPUS; HUMANS; MICROTUBULES; NEUROFIBRILLARY TANGLES; TAU PROTEINS;

EID: 0031711244     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000007969     Document Type: Review

References (115)

1. Roca WA, Hofman A, Brayne C, Breteler MMB, Clarke M, Copeland JRM, Dartigues JF, Engedal K, Hagnell O, Heeren TJ, Jonker C, Lindesay J, Lobo A, Mann AH, Mölsä PK, Morgan K, O'Connor DW, Da Silva Droux A, Sulkava R, Kay DWK, Amaducci L: Frequency and distribution of Alzheimer's disease in Europe: A collaborative study of 1980-1990 prevalence findings. Ann Neurol 1991;30:381-390.
2. Levy-Lahad E, Brid TD: Genetic factors in Alzheimer's disease: A review of recent advances. Ann Neurol 1996;40:829-840.
3. Roses AD: Apolipoprotem E alleles as risk factors in Alzheimer's disease. Annu Rev Med 1996;47:387-400.
4. Kidd M: Paired helical filaments in electron microscopy of Alzheimer's disease. Nature 1963;197:192-193.
5. Pollanen MS, Markiewicz P, Goh MC: Paired helical filaments are twisted ribbons composed of two parallel and aligned components: Image reconstruction and modeling of filament structure using atomic force microscopy. J Neuropathol Exp Neurol 1997;56:79-85.
6. Ruben GC, Iqbal K, Grundke-Iqbal I, Johnson JE Jr: The organization of the microtubule associated protein tau in Alzheimer paired helical filaments. Brain Res 1993;602:1-13.
7. Crowther RA, Wischik CM: Image reconstruction of the Alzheimer paired helical filament. EMBO J 1985;4:3661-3665.
8. Lamy C, Duyckaerts C, Delaere P, Payan C, Fermanian J, Poulain V, Hauw JJ: Comparison of seven staining methods for senile plaques and neurofibrillary tangles in a prospective series of 15 elderly patients. Neuropathol Appl Neurobiol 1989;15:563-578.
9. Duyckaerts C, Brion JP, Hauw JJ, Flament-Durand J: Comparison of immunocytochemistry with a specific antibody and Bodian's protargol method. Quantitative assessment of the density of neurofibrillary tangles and senile plaques in senile dementia of the Alzheimer type. Acta Neuropathol (Berl) 1987;73:167-170.
10. Duyckaerts C, Delaère P, Hauw JJ, Abbamondi-Pinto AL, Sorbi S, Allen L, Brion JP, Flament-Durand J, Duchen L, Kauss J, Schlote W, Lowe J, Probst A, Ravid R, Swaab DF, Renkawek K, Tomlinson B: Rating of lesions in senile dementia of the Alzheimer type: Concordance between laboratories. A European multicenter study under the auspices of Eurage. J Neurol Sci 1990;97:295-323.
11. Bancher C, Brunner C, Lassmann H, Budka H, Jellinger K, Wiche G, Seitelberger E, Grundke-Iqbal L, Iqbal K, Wisniewski HM: Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease. Brain Res 1989;477: 90-99.
12. Braak E, Braak H, Mandelkow E-M: A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol (Berl) 1994;87: 554-567.
13. Cras P, Smith MA, Richey PL, Siedlak SL, Mulvihill P, Perry G: Extracellular neurofibrillary tangles reflect neuronal loss and provide further evidence of extensive protein crosslinking in Alzheimer disease. Acta Neuropathol (Berl) 1995;89:291-295.
14. Bondareff W, Harrington C, Wischik CM, Hauser DL, Roth M: Immunohistochemical staging of neurofibrillary degeneration in Alzheimer's disease. J Neuropathol Exp Neurol 1994;53:158-164.
15. Brion JP, Hanger DP, Bruce MT, Couck AM, Flament-Durand J, Anderton BH: Tau in Alzheimer neurofibrillary tangles: N- and C-terminal regions are differentially associated with paired helical filaments and the location of a putative abnormal phosphorylation site. Biochem J 1991;273:127-133.
16. Delaère P, Duyckaerts C, Brion JP, Poulain V, Hauw JJ: Tau, paired helical filaments and amyloid in the neocortex: a morphometric study of 15 cases with graded intellectual status in aging and senile dementia of Alzheimer type. Acta Neuropathol (Berl) 1989;77:645-653.
17. Probst A, Anderton BH, Brion JP, Ulrich J: Senile plaque neurites fail to demonstrate anti-paired helical filaments and anti-microtubule-associated protein tau immunoreactive proteins in the absence of neurofibrillary tangles in the neocortex. Acta Neuropathol (Berl) 1989; 77:430-436.
18. Octave JN: The amyloid peptide and its precursor in Alzheimer's disease. Rev Neurosci 1995;6:287-316.
19. Dickson DW: The pathogenesis of senile plaques. J Neuropathol Exp Neurol 1996;56: 321-339.
20. Gómez-Isla T, Hollister R, West H, Mui S, Growdon JH, Petersen RC, Parisi JE, Hyman BT: Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann Neurol 1997;41:17-24.
21. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R: Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment. Ann Neurol 1991;30:572-580.
22. Khachaturian ZS: Diagnosis of Alzheimer's disease. Arch Neurol 1985;42:1097-1105.
23. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-486.
24. Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT: Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 1992;42:631-639.
25. The National Institute on Aging and Reagan Institute working group on diagnostic criteria for the neuropathologic E assessment of Alzheimer's disease: Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiol Aging 1997;18:S1-S2.
26. Arnold SE, Hyman BT, Flory J: The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in cerebral cortex of patients with Alzheimer's disease. Cereb Cortex 1991;1:103-116.
27. Braak H, Braak E: Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 1991;82:239-259.
28. Duyckaerts C, Bennecib M, Grignon Y, Uchihara T, He Y, Piette F, Hauw JJ: Modeling the relation between neurofibrillary tangles and intellectual status. Neurobiol Aging 1997;18: 267-273.
29. Price JL, Davis PB, Morris JC, White DL: The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease. Neurobiol Aging 1991;12:295-312.
30. Brion JP, Résibois A: A subset of calretinin-positive neurons are abnormal in Alzheimer's disease. Acta Neuropathol (Berl) 1994;88:33-43.
31. Morrison JH, Hof PR: Life and death of neurons in the aging brain. Science 1997;278:412-419.
32. Feany MB, Dickson DW: Neurodegenerative disorders with extensive tau pathology: A comparative study and review. Ann Neurol 1996; 40:139-148.
33. Wisniewski K, Jervis JA, Moretz RC, Wisniewski HM: Alzheimer neurofibrillary tangles in diseases other than senile and presenile dementia. Ann Neurol 1979;5:288-294.
34. Delaère P, Duyckaerts C, Masters C, Beyreuther K, Piette F, Hauw J-J: Large amounts of neocortical βA4 deposits without neuritic plaques nor tangles in a psychometrically assessed, non-demented person. Neurosci Lett 1990;116:87-93.
35. Delacourte A, Buée L: Normal and pathological tau proteins as factors for microtubule assembly. Int Rev Cytol 1997;171:167-224.
36. Nelson PT, Greenberg SG, Saper CB: Neurofibrillary tangles in the cerebral cortex of sheep. Neurosci Lett 1994;170:187-190.
37. Giaccone G, Verga L, Finazzi M, Polio B, Tagliavini F, Frangione B, Bugiani O: Cerebral preamyloid deposits and congophilic angiopathy in aged dogs. Neurosci Lett 1990;114:178-183.
38. Vandermeeren M, Mercken M, Vanmechelen E, Six J, Van De Voorde A, Martin J-J, Cras P: Detection of τ proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay. J Neurochem 1993;61:1828-1834.
39. Vigo-Pelfrey C, Seubert P, Barbour R, Blomquist C, Lee M, Lee D, Coria F, Chang L, Miller B, Lieberburg I, Schenk D: Elevation of microtubule-associated protein tau in the cerebrospinal fluid of patients with Alzheimer's disease. Neurology 1995;45:788-793.
40. Galasko D, Clark C, Chang L, Miller B, Green RC, Motter R, Seubert P: Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's disease. Neurology 1997;48:632-635.
41. Weingarten MD, Lockwood AH, Hwo SH, Kirschner MW: A protein factor essential for microtubule assembly. Proc Natl Acad Sci USA 1975;72:1858-1862.
42. Goedert M, Spillantini MG, Cairns NJ, Crowther RA: Tau proteins of Alzheimer paired helical filaments: Abnormal phosphorylation of all six brain isoforms. Neuron 1992;8: 159-168.
43. Couchie D, Mavilia C, Georgieff IS, Liem RKH, Shelanski ML, Nunez J: Primary structure of high molecular weight tau present in the peripheral nervous system. Proc Natl Acad Sci USA 1992;89:4378-4381.
44. Brion JP, Octave JN, Couck AM: Distribution of the phosphorylated microtubule-associated protein tau in developing cortical neurons. Neuroscience 1994;63:895-909.
45. Binder LI, Frankfurter A, Rebhun I: The distribution of tau in the mammalian central nervous system. J Cell Biol 1985;101:1371-1378.
46. Brion JP, Guilleminot J, Couchie D, Nunez J: Both adult and juvenile tau microtubule-associated proteins are axon specific in the developing and adult rat cerebellum. Neuroscience 1988;25:139-146.
47. Tashiro K, Hasegawa M, Ihara Y, Iwatsubo T: Somatodendritic localization of phosphorylated tau in neonatal and adult rat cerebral cortex. Neuroreport 1997;8:2797-2801.
48. Brion JP, Smith C, Couck AM, Gallo JM, Anderton BH: Developmental changes in tau phosphorylation: Fetal-type tau is transiently phosphorylated in a manner similar to paired helical filament-tau characteristic of Alzheimer's disease. J Neurochem 1993;61:2071-2080.
49. Brion JP, Passareiro H, Nunez J, Flament-Durand J: Mise en évidence immunologique de la protéine tau au niveau des lésions de dégénérescence neurofibrillaire de la maladie d'Alzheimer. Arch Biol (Brux) 1985;95:229-235.
50. Delacourte A, Defossez A: Alzheimer's disease: tau proteins, the promoting factors of microtubule assembly, are major components of paired helical filaments. J Neurol Sci 1986;76:173-186.
51. Goedert M, Wischik CM, Crowther RA, Walker JE, Klug A: Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: Identification as the microtubule-associated protein tau. Proc Natl Acad Sci USA 1988;85:4051-4055.
52. Grundke-Iqbal I, Iqbal K, Quinlan M, Tung YC, Zaidi MS, Wisniewski HM: Microtubule-associated protein tau: A component of Alzheimer paired helical filaments. J Biol Chem 1986;261:6084-6089.
53. Kosik KS, Joachim CL, Selkoe DJ: The microtubule-associated protein, tau, is a major antigenic component of paired helical filaments in Alzheimer's disease. Proc Natl Acad Sci USA 1986;83:4044-4048.
54. Nukina N, Ihara Y: One of the antigenic determinants of paired helical filaments is related to tau protein. J Biochem 1986;99:1541-1544.
55. Wood JG, Mirra SS, Pollock NJ, Binder LI: Neurofibrillary tangles of Alzheimer disease share antigenic determinants with the axonal microtubule-associated protein tau. Proc Natl Acad Sci USA 1986;83:4040-4043.
56. Wille H, Drewes G, Biernat J, Mandelkow E-M, Mandelkow E: Alzheimer-like paired helical filaments and antiparallel dimers formed from microtubule-associated protein tau in vitro. J Cell Biol 1992;118:573-584.
57. Brion JP, Hanger DP, Couck AM, Anderton BH: A68 proteins in Alzheimer's disease are composed of several tau isoforms in a phosphorylated state which affects their electrophoretic mobilities. Biochem J 1991;279:831-836.
58. Grundke-Iqbal L, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI: Abnormal phosphorylation of the microtubule-associated protein tau in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 1986;83:4913-4917.
59. Lee VMY, Balin BJ, Otvos L, Trojanowski JQ: A68 proteins are major subunits of Alzheimer disease paired helical filaments and derivatized forms of normal tau. Science 1981;251:675-678.
60. Morishima-Kawashima M, Hasegawa M, Takio K, Suzuki M, Yoshida H, Titani K, Ihara Y: Proline-directed and non-proline-directed phosphorylation of PHF-tau. J Biol Chem 1995;270:823-829.
61. Matsuo ES, Shin R-W, Billingsley ML, Van De Voorde A, O'Connor M, Trojanowski JQ, Lee VM-Y: Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau. Neuron 1994;13:989-1002.
62. Flament S, Delacourte A, Hémon B, Défossez A: Characterization of two pathological tau protein variants in Alzheimer brain cortices. J Neurol Sci 1989;92:133-141.
63. Delacourte A, Robitaille Y, Sergeant N, Buée L, Hof PR, Wattez A, Laroche-Cholette A, Mathieu J, Chagnon P, Gauvreau D: Specific pathological Tau protein variants characterize Pick's disease. J Neuropathol Exp Neurol 1996;55:159-168.
64. Bramblett GT, Trojanowski JQ, Lee VM-Y: Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-compentent τ-isoforms (A68 proteins). Lab Invest 1992;66:212-222.
65. Mukaetova-Ladinska EB, Harrington CR, Roth M, Wischik CM: Biochemical and anatomical redistribution of tau protein in Alzheimer's disease. Am J Pathol 1993;143:565-578.
66. Schweers O, Mandelkow EM, Biernat J, Mandelkow E: Oxidation of cysteine-322 in the repeat domain of microtubule-associated protein tau controls the in vitro assembly of paired helical filaments. Proc Natl Acad Sci USA 1995;92:8463-8467.
67. Perry G, Friedman R, Shaw G, Cahu V: Ubiquitin is detected in neurofibrillary tangles and senile plaque neuntes of Alzheimer disease brains. Proc Natl Acad Sci USA 1987;84:3033-3036.
68. Ledesma MD, Bonay P, Avila J: τ protein from Alzheimer's disease patients is glycated at its tubulin-binding domain. J Neurochem 1995; 65:1658-1664.
69. Sparkman DR, Goux WJ, Jones CM, White CL III, Hill SJ: Alzheimer disease paired helical filament core structures contain glycolipid. Biochem Biophys Res Commun 1991;181: 771-779.
70. Brion JP, Cheetham ME, Couck AM, Flament-Durand L, Hanger DP, Anderton BH: Characterization of a partial cDNA specific for the high molecular weight microtubule-associated protein MAP2 that encodes epitopes shared with paired helical filaments of Alzheimer's disease. Dementia 1990;1:304-315.
71. Smith MA, Siedlak SL, Richey PL, Mulvihill P, Ghiso J, Frangione B, Tagliavini F, Giaccone G, Bugiani O, Praprotnik D, Kalaria RN, Perry G: Tau protein directly interacts with the amyloid β-protein precursors: Implications for Alzheimer's disease. Nature Med 1995;1:365-369.
72. Snow AD, Lara S, Nochlin D, Wight TN: Cationic dyes reveal proteoglycans structurally integrated within the characteristic lesions of Alzheimer's disease. Acta Neuropathol Berl 1989; 78:113-123.
73. Miller CCJ, Brion JP, Calvert R, Chin TK, Eagles PAM, Downes MJ, Haugh M, Kahn J, Probst A, Ulrich J, Anderton BH: Alzheimer paired helical filaments share epitopes with neurofilaments side arms. EMBO J 1986;5: 269-276.
74. Goedert M, Jakes R, Spillantini MG, Hasegawa M, Smith MJ, Crowther RA: Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans. Nature 1996;383:550-553.
75. Van SD, Van SF, Chen X, Fu J, Chen M, Kuppusamy P, Smith MA, Perry G, Godman GC, Nawroth P, Zweiter JL, Stern D: Nonenzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid β-peptide. Nature Med 1995;1:693-699.
76. Terry RD: The pathogenesis of Alzheimer disease: An alternative to the amyloid hypothesis. J Neuropathol Exp Neurol 1996;55:1023-1025.
77. Flament-Durand J, Couck AM: Spongiform alterations in brain biopsies of presenile dementia. Acta Neuropathol (Berl) 1979;46:159-162.
78. Gray EG, Paula-Barbosa M, Roher A: Alzheimer's disease: Paired helical filaments and cytomembranes. Neuropathol Appl Neurobiol 1987;13:91-110.
79. Dustin P, Flament-Durand J: Disturbances of axoplasmic transport in Alzheimer's disease; in Weiss DG, Gorio A (eds): Axoplasmic Transport in Physiology and Pathology. Berlin, Springer, 1982, pp 131-136.
80. Richard S, Brion JP, Couck AM, Flament-Durand J: Accumulation of smooth endoplasmic reticulum in Alzheimer's disease: New morphological evidence of axoplasmic flow disturbances. J Submicrosc Cytol 1989;21: 461-467.
81. Terry RD, Gonatas NK, Weiss M: Ultrastructural studies in Alzheimer's presenile dementia. Am J Pathol 1964;44:669-697.
82. Hempen BJ, Brion JP: Reduction of acetylated a-tubulin immunoreactivity in neurofibrillary tangle-bearing neurones in Alzheimer's disease. J Neuropathol Exp Neurol 1996;55:964-972.
83. Iqbal K, Grundke-Iqbal L, Zaidi T, Merz PA, Wen GY, Shaikh SS, Wisniewski HM: Defective brain microtubule assembly in Alzheimer's disease. Lancet 1986;i:421-426.
84. Lu Q, Wood JG: Functional studies of Alzheimer's disease tau protein. J Neurosci 1993; 13:508-515.
85. Alonso AD, Grundke-Iqbal I, Iqbal K: Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules. Nature Med 1996;2:783-787.
86. Roses AD, Einstein G, Gilbert J, Goedert M, Han SH, Huang D, Hulette C, Masliah E, Pericak-Vance MA, Saunders AM, Schmechel DE, Strittmatter WJ, Weisgraber KH, Xi PT: Morphological, biochemical, and genetic support for an apolipoprotein E effect on microtubular metabolism. Ann NY Acad Sci 1996;777:146-157.
87. Mercken L, Brion JP: Phosphorylation of tau protein is not affected in mice lacking apolipoprotein E. Neuroreport 1995;6:2381-2384.
88. Billingsley ML, Kincaid RL: Regulated phosphorylation and dephosphorylation of tau protein: Effects on microtubule interaction, intracellular trafficking and neurodegeneration. Biochem 1997;323:577-591.
89. Trojanowski JQ, Lee VMY: Phosphorylation of paired helical filament tau in Alzheimer's disease neurofibrillary lesions: Focusing on phosphatases. FASEB J 1995;9:1570-1576.
90. Dupont-Wallois L, Sautière PE, Cocquerelle C, Bailleul B, Delacourte A, Caillet-Boudin ML: Shift from fetal-type to Alzheimer-type phosphorylated Tau proteins in SKNSH-SY 5Y cells treated with okadaic acid. FEBS Lett 1995;357:197-201.
91. Davis DR, Brion JP, Couck A-M, Gallo J-M, Hanger DP, Ladhani K, Lewis C, Miller CCJ, Rupniak T, Smith C, Anderton BH: The phosphorylation state of the microtubule-associated protein tau as affected by glutamate, colchicine and β-amyloid in primary rat cortical neuronal cultures. Biochem J 1995;309: 941-949.
92. Davis DR, Anderton BH, Brion JP, Reynolds HG, Hanger DP: Oxidative stress induces dephosphorylation of tau in rat brain primary neuronal cultures. J Neurochem 1997;68: 1590-1597.
93. Adamec E, Mercken M, Beermann ML, Didier M, Nixon RA: Acute rise in the concentration of free cytoplasmic calcium leads to dephosphorylation of the microtubule-associated protein tau. Brain Res 1997;757:93-101.
94. Papasozomenos SC, Su Y: Rapid dephosphorylation oft in heat-shocked fetal rat cerebral explants: Prevention and hyperphosphorylation by inhibitors of protein phosphatases PP1 and PP2A. J Neurochem 1995;65:396-406.
95. Geddes JW, Schwab C, Craddock S, Wilson JL, Pettigrew LC: Alterations in T immunostaining in the rat hippocampus following transient cerebral ischemia. J Cereb Blood Flow Metab 1994;14:554-564.
96. Brion JP, Couck AM, Conreur JL: Calcineurin (phosphatase 2B) is present in neurons containing neurofibrillary tangles and in a subset of senile plaques in Alzheimer's disease. Neurodegeneration 1995;4:13-21.
97. Hanger DP, Hughes K, Woodgett JR, Brion JP, Anderton BH: Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: Generation of paired helical filaments epitopes and neuronal localization of the kinase. Neurosci Lett 1992;147:58-62.
98. Trojanowski JQ, Mawal-Dewan M, Schmidt ML, Martin J, Lee VM-Y: Localization of the mitogen activated protein kinase ERK2 in Alzheimer's disease neurofibrillary tangles and senile plaque neuntes. Brain Res 1993; 618:333-337.
99. Vincent I, Jicha G, Rosado M, Dickson DW: Aberrant expression of mitotic Cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain. J Neurosci 1997;17: 3588-3598.
100. Lovestone S, Reynolds CH, Latimer D, Davis DR, Anderton BH, Gallo J-M, Hanger D, Mulot S, Marquardt B, Stabel S, Woodgett JR, Miller CCJ: Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells. Curr Biol 1994;4:1077-1086.
101. Lovestone S, Hartley CL, Pearce J, Anderton BH: Phosphorylation of tau by glycogen synthase kinase-3β in intact mammalian cells: The effects on the organization and stability of microtubules. Neuroscience 1996;73: 1145-1157.
102. Mulot SFC, Hughes K, Woodgett JR, Anderten BH, Hanger DP: PHF-tau from Alzheimer's brain comprises four species on SDS-PAGE which can be mimicked by in vitro phosphorylation of human brain tau by glycogen synthase kinase-3β. FEBS Lett 1994; 349:359-364.
103. Su JH, Anderson AJ, Cummings BJ, Cotman CW: Immunohistochemical evidence for apoptosis in Alzheimer's disease. Neuroreport 1994;5:2529-2533.
104. Lassmann H, Bancher C, Breitschopf H, Wegiel J, Bobinski M, Jellinger K, Wisniewski HM: Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropathol (Berl) 1995;89:35-41.
105. Hardy J: Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci 1997;20: 154-159.
106. Borchelt DR, Ratovitski T, Van Lare J, Lee MK, Gonzales V, Jenkins NA, Copeland NG, Price DL, Sisodia SS: Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron 1997;19: 939-945.
107. Mann DMA, Esiri MM: The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down's syndrome. J Neurol Sci 1989;89:169-179.
108. Busciglio J, Lorenzo A, Yeh J, Yankner BA: β-amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron 1995;14:879-888.
109. Sturchler-Pierrat C, Abramowski D, Duke M, Wiederhold KH, Mistl C, Rothacher S, Ledermann B, Bürki K, Frey P, Paganetti PA, Waridel C, Calhoun ME, Jucker M, Probst A, Staufenbiel M, Sommer B: Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci USA 1997;94:13287-13292.
110. Wujek JR, Dority MD, Frederickson RCA, Brunden KR: Deposits of Aβ fibrils are not toxic to cortical and hippocampal neurons in vitro. Neurobiol Aging 1996;17:107-113.
111. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang FS, Cole G: Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science 1996;274:99-102.
112. Philippe B, Brion JP, Octave JN: Generation of a monoclonal antibody to the carboxy-terminal domain of tau by immunization with ammo-terminal domain of the amyloid precursor protein. J Neurosci Res 1996;46:709-719.
113. Brion JP, Tremp G, Octave JN: Somatodendritic accumulation of human phosphorylated tau in transgenic mice mimicks early stages of Alzheimer-type neurofibrillary degeneration. Eur J Neurosci, submitted.
114. Götz J, Probst A, Spillantini MG, Schäfer T, Jakes R, Bürki K, Goedert M: Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform. EMBO J 1995;14:1304-1313.
115. Sergeant N, Bussière T, Vermersch P, Lejeune JP, Delacourte A: Isoelectric point differentiates PHF-tau from biopsy-derived human brain tau proteins. Neuroreport 1995;6: 2217-2220.